Hongxia Shi

Beijing Key Laboratory Of Hematopoietic Stem Cell Transplantation
Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Prognostic covariates associated with outcomes in patients with NPM1-mutated acute myeloid leukemia.

Prognostic covariates associated with outcomes in patients with NPM1-mutated acute myeloid leukemia.

Journal: The oncologist

Published: July 17, 2025

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review.

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review.

Journal: Frontiers in oncology

Published: June 10, 2025

IKZF1 Variants Predicted Poor Outcomes in Acute Myeloid Leukemia Patients with CEBPA bZIP In-Frame Mutations.

IKZF1 Variants Predicted Poor Outcomes in Acute Myeloid Leukemia Patients with CEBPA bZIP In-Frame Mutations.

Journal: Cancers

Published: June 09, 2025

Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia.

Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia.

Journal: Annals of hematology

Published: August 05, 2024

Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival.

Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival.

Journal: Annals of hematology

Published: June 10, 2024

Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey.

Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey.

Journal: Acta haematologica

Published: April 29, 2024

Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.

Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.

Journal: Annals of hematology

Published: April 22, 2024

The impact of Bruton's tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia.

The impact of Bruton's tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia.

Journal: Frontiers in oncology

Published: March 06, 2024

Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia.

Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia.

Journal: Annals of hematology

Published: November 25, 2023

Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.

Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.

Journal: Annals of hematology

Published: July 28, 2023

Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study.

Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study.

Journal: Annals of hematology

Published: April 01, 2023

Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review.

Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review.

Journal: Renal failure

Published: January 12, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026